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Figure captions 
Figure 1.  Flow chart of the process and rationale used in selecting papers for inclusion in the 
review, using a highly sensitive search strategy. 
Figure 2.  Standardised mean difference for improvement in pain with multimodal 
physiotherapy.  MMP = multimodal physiotherapy; Ed = education; FO = foot orthoses; Ex = 
exercise. 
Figure 3.  Standardised mean difference for improvement in pain with exercise intervention.  
CKC = closed kinetic chain; OKC = open kinetic chain; Ex = exercise; add = adduction; Ed = 
education; quads = quadriceps; MT = manual therapy; FO = foot orthoses. 
Figure 4.  Standardised mean difference for improvement in pain with manual therapy, tape, 
foot orthoses or electrotherapy intervention. MT = manual therapy; manip = manipulation; Ex = 
exercise; ST = soft tissue treatment; FKC = full kinetic chain; Ed = education; FO = foot orthoses; 
MMP = multimodal physiotherapy; EMG = electromyography; EMS = electric muscle stimulation.  
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Abstract 
Anterior knee pain is a chronic condition that presents frequently to sports medicine clinics, and can 
have a long-term impact on active participation.  Conceivably, effective early management may 
prevent chronicity and facilitate physical activity.  Although a variety of non-surgical interventions 
have been advocated, previous systematic reviews have consistently been unable to reach 
conclusions to support their use.  Considering a decade has lapsed since publication of the most 
recent data in these reviews, it is timely to provide an updated synthesis of the literature to assist 
sports medicine practitioners make informed, evidence-based decisions.  A systematic review and 
meta-analysis was conducted to evaluate the evidence for non-surgical interventions for anterior 
knee pain. 
 
A comprehensive search strategy was used to search MEDLINE, EMBASE, CINAHL and Pre-
CINAHL, PEDro, PubMed, Sportdiscus, Web of Science, Biosis Previews, and the full Cochrane 
Library, while reference lists of included papers and previous systematic reviews were hand 
searched.  Studies were eligible for inclusion if they were randomised clinical trials that used a 
measure of pain to evaluate at least one non-surgical intervention over at least two weeks in 
participants with anterior knee pain.  A modified version of the PEDro scale was used to rate 
methodological quality and risk of bias.  Effect size calculation and meta-analyses were based on 
random effects models. 
 
Of 48 suitable studies, 27 studies with low to moderate risk of bias were included.  There was 
minimal opportunity for meta-analysis due to heterogeneity of interventions, comparators and 
follow up times.  Meta-analysis of high quality clinical trials supports the use of a six-week 
multimodal physiotherapy program (standardised mean difference 1.08, 95% confidence interval 
0.73, 1.43), but does not support the addition of electromyography biofeedback to an exercise 
program in the short-term (four weeks: -0.21, -0.64 to 0.21; eight to 12 weeks: -0.22, -0.65 to 0.20).  
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Individual study data showed beneficial effects for foot orthoses with and without multimodal 
physiotherapy (versus flat inserts), exercise (versus control), closed chain exercises (versus open 
chain exercises), patella taping in conjunction with exercise (versus exercise alone), and 
acupuncture (versus control).   
 
Findings suggest that, in implementing evidence-based practice for the non-surgical management of 
anterior knee pain, sports medicine practitioners should prescribe local, proximal and distal 
components of multimodal physiotherapy in the first instance for suitable patients, then consider 
foot orthoses or acupuncture as required. 
 
 6 
1. Background 
Anterior knee pain (AKP), or patellofemoral pain syndrome, is a chronic musculoskeletal overuse 
condition presenting frequently to sports medicine and general practitioners.[1-8]  It affects an 
individual’s ability to perform routine daily activities such as stair ambulation, walking and 
running, and thus impacts on work-related activities and participation in physical activity.  Findings 
from prospective studies in active populations [9-11] reflect the chronicity of AKP, with a 
randomised controlled trial (RCT) reporting no recovery in half of the no-treatment control group at 
12 months.[11]  Furthermore, it is plausible that AKP in adults may precede the development of 
osteoarthritis in later years.[12]  
 
Despite its prevalence, chronicity and impact, AKP remains one of the most challenging 
musculoskeletal conditions managed by practitioners.[13]  Since greater pain severity and longer 
symptom duration are predictive of poor prognosis,[14] early effective management may be the key 
to limiting the longer-term impact of the condition.  Considering the multifactorial nature of 
patellofemoral pain [15, 16], the management approach should consider individual presentation and 
the contribution of local knee factors, as well as potential proximal (hip) and distal (foot) factors. 
 
Surgical options for AKP appear to be inadequate.[17]  This is highlighted by a RCT that revealed 
no additional improvement in AKP symptoms and function over nine months when arthroscopic 
procedures based on pragmatically-identified abnormalities (e.g. resection of 
inflamed/scarred/excessive medial plicae or synovium, abrasion of chondral lesions, discision of 
lateral capsule, repair of meniscal tears) was added to exercise therapy.[18]  Consequently, there is 
widespread consensus that non-surgical interventions are the primary treatment of choice for AKP.  
However, in order to make informed decisions regarding optimal management, practitioners require 
up-to-date, high quality evidence.  Systematic reviews have drawn limited conclusions regarding 
RCT evidence for non-surgical interventions for AKP.[19-26]  From these, it appears that there is 
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moderate evidence to support the short-term use of patellar taping for chronic knee pain,[19, 26] 
however meta-analyses conducted by one review collapsed findings for nonarthritic AKP and 
patellofemoral joint osteoarthritis.[26]  Considering the recent increase in research output regarding 
AKP interventions, it is timely for an updated high-quality systematic review to assist practitioners 
make informed, evidence-based decisions when managing AKP.[27]  Therefore, a systematic 
review and meta-analysis, where possible, was conducted to evaluate the evidence for the short- and 
long-term efficacy of non-surgical interventions for AKP. 
 
2. Methodology 
The study protocol was developed in consultation with guidelines provided by the PRISMA 
Statement.[28] 
 
2.1. Literature search strategy 
Using guidelines provided by the Cochrane Collaboration,[29] a comprehensive search strategy was 
devised for the following databases:  MEDLINE, EMBASE, CINAHL and Pre-CINAHL, PEDro, 
PubMed, Sportdiscus, Web of Science, Biosis Previews, and the full Cochrane Library.  The 
MEDLINE search strategy, which was adapted for other databases, is presented in Appendix 1.  All 
publications listed up until 30 November 2009 were considered for inclusion, with no restrictions 
placed on year of publication.  Only full text, English language articles were included.  Published 
abstracts were followed up for full text publications of the study, but were not included as stand-
alone papers.  One investigator (NC) reviewed all titles returned by the database searches, and 
retrieved suitable abstracts.  Where abstracts suggested that papers were potentially suitable, the full 
text versions were obtained and included in the review if found to fulfil the selection criteria.  
Reference lists of included papers and known published systematic reviews were hand searched to 
ensure the inclusion of all available published evidence. 
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2.2. Selection criteria 
Studies were eligible for inclusion if they investigated participants who had an insidious onset of 
anterior or retropatellar knee pain aggravated by activities that load the patellofemoral joint (PFJ) 
(e.g. prolonged sitting or kneeling, squatting, jogging or running, hopping, jumping, or stair 
ascending/descending).[30, 31]  Studies were required to have investigated one or more non-
surgical interventions for AKP, compared to a control intervention, over a minimum period of one 
week.  The design must have been a clinical trial that i) followed participants over at least two 
weeks (deemed to be a clinically meaningful time period); ii) utilised an outcome measure of pain; 
such as pain measured on an 11-point numeric rating scale (NRS) or 100 millimetre visual analogue 
scale (VAS); and iii) randomly assigned participants to intervention groups using methods defined 
by PEDro rating scale criterion 2 (Appendix 2).[32]  Studies were excluded if they presented results 
reported in a previous publication or if their sole focus was chondromalacia patella verified by 
imaging or arthroscopy. 
 
2.3. Assessment of methodological quality and risk of bias 
The methodological quality of included studies was rated using a modified version of the PEDro 
rating scale [32] (Appendix 2).  This scale has been used in previous systematic reviews with very 
high inter-rater agreement (κ 0.73 to 0.824).[33, 34]  Two independent reviewers (NC, LB), one of 
who remained blind to authors, affiliations and the publishing journal (LB), rated each study on 14 
specific criteria.  Final study ratings for each reviewer were collated and examined for 
discrepancies.  Any inter-rater disagreement was discussed in a consensus meeting, and unresolved 
items taken to an independent party (BV) for resolution.  Once consensus was reached for all study 
ratings, overall quality scores were determined for each study by summing those criteria that had 
scored “yes”, providing a score out of 14.  
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Risk of bias was assessed using specific criteria from the modified PEDro scale, selected based on 
the PRISMA Statement [28] and the Cochrane Collaboration.[35]  These were: adequacy of 
randomisation (criterion two); allocation concealment (criterion three); between-group baseline 
comparability (criterion four); blinding of outcome assessors (criterion seven); adequate follow-up 
(more than 85%) (criterion eight); and intention to treat analysis (criterion nine).  A lack of blinding 
of participants and therapists was not considered to be a source of bias for these studies, as it is 
often not plausible to blind those providing and receiving interventions such as physiotherapy and 
specific exercises, particularly when the efficacy of two different interventions is compared.  The 
RCTs were classified as having a low risk of bias (score 5 or 6 out of the 6 criteria), moderate risk 
(3 or 4) or high risk (≤ 2); the latter were excluded from further analysis.   
 
2.4. Data management and statistical analysis 
Inter-rater reliability of the modified PEDro scores was evaluated using the kappa (κ) statistic, 
where a κ of 0.9 to 1 represented almost perfect to perfect agreement, 0.7 to 0.9 very high 
agreement, 0.5 to 0.7 high agreement, 0.3 to 0.5 moderate agreement, 0.1 to 0.3 small agreement, 
and 0 to 0.1 very small agreement.[36] 
 
Standardised mean differences (SMD) with 95% confidence intervals were used to represent effect 
sizes for pain, and were calculated using a random effects model in Review Manager (Version 
4.2).[37]  For studies that reported outcome on multiple pain scales, participant reported worst pain 
intensity over the previous week or a similar scale (e.g. pain with activity) was used.  Data were 
grouped by follow-up time (0 to 6 weeks, 7 to 12 weeks, 13 to 26 weeks, greater than 26 weeks), 
using the latest time point in each period.  Where possible, mean change scores and standard 
deviations were extracted from papers to calculate SMDs.  Alternatively, mean change scores were 
calculated by subtracting the follow-up score from the baseline score, and the standard deviation 
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estimated by taking the average of the pre- and post-score standard deviations [38] or 95% 
confidence intervals.  When insufficient data prevented calculation of change scores, raw follow-up 
scores were used when groups were not significantly different on baseline measures from a clinical 
perspective (greater than 15 millimetres on a 100 millimetre pain VAS [39, 40]).  Authors were 
contacted by email for clarification or provision of additional data.  Effect size magnitudes were 
interpreted as being nearly perfect (SMD ≥ 4), very large (2 to 4), large (1.2 to 2), moderate (0.6 to 
1.2), small (0.2 to 0.6) and trivial (< 0.2),[36] with positive values favouring the intervention of 
interest.  A null effect was represented by a SMD with a confidence interval that crossed (but were 
not bound by) zero.  Data were pooled where studies investigated similar interventions, and had 
similar comparator interventions and timing of follow-up outcome measures. 
 
Sensitivity analyses were conducted to confirm the exclusion of papers with a high risk of bias.  
Since studies with higher quality scores return findings of reduced efficacy of treatment,[41] 
Spearman’s correlation coefficients were calculated to determine the strength of the relationship 
between risk of bias (low, moderate, high) and effect size (SMD), and between modified PEDro 
scale score and effect size.  The strength of correlations was determined using the same 
classification as for the κ statistic.[36] 
  
3. Results 
3.1. Search strategy 
The comprehensive search strategy identified 605 publications for evaluation beyond title (Figure 
1).  The full text of 188 articles was retrieved, with 48 of these meeting the inclusion criteria.   
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3.2. Methodological quality and risk of bias 
The 48 studies scored widely on the modified PEDro scale, ranging from two to 13 out of 14 (mean 
score 6.58) (see supplementary file).  Criteria satisfied by less than half of the included papers were 
allocation concealment (criterion three, 29%), blinding (criterion five, 8%; criterion six, 2%; 
criterion seven, 41%), intention to treat analysis (criterion nine, 22%), justification of sample size 
(criterion 12, 37%), and reporting of adverse or side effects (criterion 14, 18%). 
 
Initial inter-rater agreement on the modified PEDro criteria was very high (619 out of 672 ratings; κ 
= 0.842).  Consensus was reached on all items on initial discussion.  Inter-rater reliability for 
individual criteria ranged from high (κ = 0.529) for criterion eleven to perfect (κ = 1.000) for 
criteria one and two. 
 
Twenty-one studies were considered to have a high risk of bias and subsequently excluded from 
further analysis (see Appendix 3 for study characteristics).  Sensitivity analyses revealed a 
significant moderate correlation between risk of bias and SMD (correlation coefficient 0.328, p = 
0.004), and between modified PEDro score and SMD (0.456, p < 0.000), supporting the exclusion 
of high-risk studies. 
 
3.3. Findings 
The 27 remaining studies were grouped by their primary intervention of interest (multimodal 
physiotherapy, manual therapy, exercise, tape, foot orthoses, electrotherapy, acupuncture, 
pharmacotherapy).  Follow-up was predominantly within three months; only six studies followed 
participants beyond this.  Table I presents characteristics of included studies with effect sizes for 
pain, and study conclusions when effect sizes could not be calculated.   
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3.3.1. Multimodal physiotherapy 
Evidence from meta-analysis supports the use of multimodal physiotherapy in the short-term.  
Pooled data from two studies that investigated identical multimodal physiotherapy programs [30, 
31] showed a significant moderate effect for multimodal physiotherapy over a placebo intervention 
(flat inserts [31]; sham physiotherapy [30]) at six weeks (SMD 1.08, 95% CI 0.73, 1.43) (Figure 2).   
 
Evidence from individual RCTs largely supports the use of multimodal physiotherapy for AKP.  
When compared to placebo, there were significant moderate effects for multimodal physiotherapy 
at 12 weeks (0.69, 0.23 to 1.14), and significant small effects at one year (0.44, 0.01 to 0.88).[31]  
When multimodal physiotherapy was compared to a no-treatment or education control, the 
inclusion of more multimodal components appeared to increase its efficacy.  Findings of Syme et al 
[42] showed significant moderate effects favouring eight weeks of manual therapy, stretches, vasti 
retraining and PFJ taping over no-treatment control (0.63, 0.00 to 1.26), but no significant effects 
were seen when only manual therapy, stretches and general lower limb exercises were used.  
However, there were contrasting effects found by Clark et al, [43] who reported no significant 
effects when a combination of exercise, patellar taping and education was compared to education 
alone at 12 weeks and one year.   
 
Effect sizes predominantly showed favourable effects for multimodal physiotherapy compared to 
other non-surgical interventions, although this appeared to be associated with timing of outcome 
measures.  From the study of Collins et al [31] there were significant small effects favouring 
multimodal physiotherapy over foot orthoses at six weeks (0.51, 0.07 to 0.95) and 12 weeks (0.45, 
0.01 to 0.88), but no significant differences at one year.  Furthermore, the addition of multimodal 
physiotherapy to foot orthoses when compared to foot orthoses alone produced significant moderate 
effects at all time points over one year (six weeks: 0.87, 0.42 to 1.32; 12 weeks: 0.63, 0.16 to 1.07; 
52 weeks: 0.70, 0.27 to 1.14).  Harrison et al [44] compared multimodal physiotherapy (patella 
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taping, vasti retraining) to a home exercise program (general lower limb strengthening and 
stretching) with and without therapist supervision over one year.  There was a significant small 
effect favouring the multimodal program over supervised exercise at four weeks (0.56, 0.00 to 
1.12).  Interestingly, multimodal physiotherapy was not significantly different to supervised or 
unsupervised exercise at 12, 26 or 52 weeks.   
 
When compared to placebo, multimodal physiotherapy used in conjunction with foot orthoses 
produced significant large effects at six weeks (1.45, 0.96 to 1.94), and significant moderate effects 
at 12 weeks (0.86, 0.40 to 1.33) and 52 weeks (0.77, 0.33 to 1.21).[31]  However, the combined 
effects of multimodal physiotherapy and foot orthoses were not significant when compared to 
physiotherapy alone at six, 12 or 52 weeks (Figure 2).  
 
3.3.2. Exercise 
Evidence from individual RCTs supports the use of various forms of exercise for AKP (Figure 3).  
Three studies showed significant effects favouring exercise over a no-treatment control.[11, 45, 46]  
Herrington and Al-Sherhi [45] compared two different six-week programs of knee extension 
exercises (closed kinetic chain; open kinetic chain) to no-treatment control.  Effect sizes calculated 
from data provided by the authors showed significant large to very large effects favouring both 
types of exercise over control (closed chain: 3.02, 1.93 to 4.11; open chain: 1.82, 0.95 to 2.69).  
Effect sizes for Song et al [46] showed significant moderate effects favouring leg press with hip 
adduction (0.83, 0.26 to 1.40) and standard leg press (1.01, 0.43 to 1.59) over control after eight 
weeks.  Similarly, findings of van Linschoten et al [11] showed significant small effects for 
supervised exercise therapy over control at 12 weeks (0.44, 0.09 to 0.78) and at one year (0.49, 0.14 
to 0.83).  
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Interestingly, time effects were found among studies that compared closed and open kinetic chain 
strengthening exercises.  Contrasting effects were found for two short-term studies, with Herrington 
and Al-Sherhi [45] showing a significant moderate effect favouring closed chain over open chain 
exercises at six weeks (1.01, 0.25 to 1.78), while a similar study by Bakhtiary et al [47] showed no 
significant effects at five weeks.  In comparison, a five-year follow-up study showed a significant 
small effect in favour of open chain exercises (-0.57, -1.14 to 0).[48]   
 
Two studies evaluated hip exercises as an addition to standard exercise programs (Figure 3).  
Findings of Nakagawa et al [49] showed no significant effect on worst pain severity for the addition 
of hip abduction and external rotation exercises to standard quadriceps exercises.  Similar outcomes 
were noted in the study of Song et al,[46] with effect sizes showing no significant effects when leg 
press was performed in hip adduction compared to the standard leg press exercise. 
 
Comparison of two groups from the study of Harrison et al [44] investigated the effect of physical 
therapist supervision of a home exercise program (Figure 3).  Effect sizes revealed no significant 
difference between supervised and unsupervised exercise at four, 12, 26 or 52 weeks.  
 
Three studies investigated the use of exercise as an adjunct to other interventions (Figure 3).  Effect 
sizes revealed no significant effect for the addition of exercise to education over 12 and 52 
weeks,[43] to patellar mobilisation/manipulation over five weeks,[50] or to foot orthoses over four 
or eight weeks.[51]   
 
3.3.3. Foot orthoses 
Evidence from one RCT supports the short-term use of foot orthoses over placebo (Figure 4).  
Collins et al [31] showed a significant small effect for foot orthoses over flat inserts at six weeks 
(0.59, 0.15 to 1.04), but no differences in effect at 12 weeks or one year. One study compared foot 
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orthoses to exercise.[51]  While effect sizes showed no significant difference at four or eight weeks, 
sample size calculations provided by the authors indicated that the study was underpowered to 
detect significant effects. 
 
Effect sizes calculated from four- and eight-week data provided by Wiener-Ogilvie and Jones [51] 
were not significant when foot orthoses were used in conjunction with exercise, compared to 
exercise alone (Figure 4), although post hoc power calculations conducted by the authors suggested 
a high likelihood of a type II error.  
 
3.3.4. Patella taping 
Evidence from one RCT supports the short-term use of patella taping (Figure 4).  Effect sizes from 
Whittingham et al [52] showed significant large to very large effects favouring four weeks of 
patella taping and exercise over exercise alone (2.47, 1.25 to 3.70), and over placebo tape with 
exercise (1.35, 0.36 to 2.35).  In contrast, longer-term data from Clark et al [43] showed no 
significant between-group effects when patella taping and education was compared to education 
alone, and when patella taping was added to exercise and education (12 and 52 weeks). 
 
3.3.5. Acupuncture 
Evidence provided by one RCT supports the use of acupuncture in AKP (Figure 4).  Effect sizes 
calculated from data provided by Jensen et al [53] showed a significant moderate effect favouring 
acupuncture treatment over control at five month follow up (0.65, 0.13 to 1.16).  Although outcome 
measures were also taken at two other time points over a year, only the acupuncture group was 
followed up at six weeks, and pain severity was not recorded at one year.   
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3.3.6. Manual therapy  
All three studies that investigated manual therapy techniques compared to control or in conjunction 
with other interventions revealed no significant findings (Figure 4).  Van den Dolder et al [54] 
showed no significant effect for two weeks of treatment with medial glide and tilt mobilisations and 
local lateral retinacular massage when compared to a no-intervention control.  Similar outcomes 
were found for joint manipulation.  Findings of Brantingham et al [55] showed no significant effect 
at six or 14 weeks for either knee manipulation or full lower limb kinetic chain manipulation when 
each was added to exercise and soft tissue treatment.  In the study by Stakes et al [56], there was no 
significant effect for the addition of spinal manipulation to patellar mobilisation over four weeks.  
 
3.3.7. Electrotherapy  
Evidence from meta-analysis does not support the use of electromyography (EMG) biofeedback in 
addition to an exercise program (Figure 4).  Pooled data from two studies [57, 58] showed no 
significant benefit of using EMG biofeedback with exercise at four weeks (-0.21, -0.64 to 0.21), or 
at eight to 12 weeks (-0.22, -0.65 to 0.20). 
 
Electric muscle stimulation (EMS) was investigated by two studies (Figure 4).[59, 60]  Effect sizes 
from Akarcali et al,[59] who evaluated the addition of high voltage pulsed galvanic stimulation to 
an exercise program, showed no significant effect for either group at six weeks.  Callaghan et al 
[60] compared different EMS devices, finding no significant effects for either simultaneous mixed 
frequency or sequential mixed frequency EMS.  One study compared low level laser treatment to 
sham laser over five weeks,[61] however insufficient data was provided for effect size calculation.  
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3.3.8. Pharmacotherapy  
One study investigated pharmacological interventions for AKP,[62] comparing one week of 
NSAIDs to placebo; however the authors did not report data for effect size calculation.  
 
4. Discussion 
The comprehensive search strategy identified a wide variety of conservative interventions for AKP 
that have been investigated by RCTs.  Meta-analyses of pain data, the primary symptom of this 
condition, provides evidence for multimodal physiotherapy when compared to a placebo over six 
weeks, as well as evidence of no additional benefit in adding EMG biofeedback to exercise over 12 
weeks.  Due to a lack of further opportunities for data pooling, the best evidence for other 
interventions such as exercise, patella taping, foot orthoses and acupuncture comes from individual 
RCTs. 
 
Findings from this review indicate that multimodal physiotherapy, compared to a placebo 
intervention that controls for therapist-patient interaction effects, has the best evidence for reducing 
AKP using a non-surgical approach.  Importantly, the magnitude represents a clinically meaningful 
improvement in pain, with the weighted mean difference of 20.3 millimetres out of 100 exceeding 
the minimal clinically important difference.[39, 40]  The two studies incorporated in the meta-
analysis received the highest ratings on the modified PEDro scale, scoring 13[30] and 12 [31] out of 
14.  Importantly, identical multimodal programs were used, and incorporated interventions targeting 
local factors (patellar taping, patellar mobilisation, vasti retraining with EMG biofeedback), 
proximal factors (gluteal strengthening) and global factors (lower limb stretches).  Syme et al [42] 
also included these components in their multimodal program, which was more efficacious than no 
treatment.  In contrast, the multimodal programs of Clark et al [43] and Harrison et al [44], who 
reported largely non-significant differences to comparators, only utilised local interventions and did 
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not target proximal or distal factors.  This suggests that the inclusion of interventions that target 
specific proximal factors,[63] as utilised by Crossley et al [30] and Collins et al [31], either in 
conjunction with local interventions or as stand-alone interventions, may be the key to ensuring 
success in reducing AKP symptoms.  Importantly, these findings highlight the multifactorial nature 
of AKP,[64] and the need for practitioners to use clinical judgement to address all necessary lower 
limb factors to effectively manage this condition.  However, more RCTs are required to facilitate 
further meta-analyses, particularly evaluating multimodal physiotherapy compared to a no-
treatment control as well as the effects of proximal interventions used in isolation.  Furthermore, 
considering that only one study investigated long-term outcomes of multimodal physiotherapy,[31] 
this should be considered in future studies. 
 
Findings of the three studies that compared exercise to wait-and-see indicate that a predominantly 
quadriceps-based program is more effective than no treatment.[11, 45, 46]  However, it appears that 
the addition of hip components, supervision, or other adjunct interventions to quadriceps-based 
programs does not change AKP outcomes.  It is important to highlight that these studies tended to 
lack specific vasti retraining, instead aiming for general quadriceps strengthening.  This may 
explain differences in effects of combined treatments when multimodal physiotherapy outcomes are 
compared to those of exercise studies.  Furthermore, these findings highlight the importance of 
targeted exercise programs based on sound clinical assessment, with consideration of additional 
components and interventions as necessary.  While it is difficult to draw conclusions regarding 
direct comparison of open and closed kinetic chain exercises, the greater emphasis on closed-chain 
exercises in the other exercise and multimodal programs suggests that this is the preferred clinical 
approach, and fits with evidence of greater vasti activity during closed than open kinetic chain 
exercises.[65] 
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It is important to note that the apparent lack of evidence for other interventions such as 
pharmacotherapy and manual therapy does not imply that these interventions are not effective; 
rather, it highlights deficits in the current literature with respect to study methodology as well as the 
need for more high-quality RCTs.  Small sample sizes utilised by some of these studies may have 
increased the risk of a type II error.  It is also important to consider those interventions that were not 
sufficiently represented in the 27 studies, such as knee braces and trunk muscle retraining.  Indeed, 
six studies evaluated the efficacy of knee and patella braces,[66-71] but were excluded due to high 
risk of bias, while only one study incorporated transversus abdominus retraining into their exercise 
program [49].  Importantly, no studies were found that investigated interventions targeted to 
individual participant presentations, such as core stability deficits.  Thus, these simple and 
commonly used interventions require further investigation utilising high-quality RCT design. 
 
This is the first systematic review to incorporate meta-analyses of data from RCTs investigating 
conservative interventions solely for nonarthritic AKP.  It also considers 23 RCTs of low to 
moderate risk of bias that were not included in the most recent published systematic review of all 
non-surgical interventions,[21] or have been published since.  New evidence from pooled data was 
found regarding multimodal physiotherapy and EMG biofeedback.  However, other non-surgical 
interventions including pharmacology require ongoing investigation.  This is particularly important 
considering the role that early effective intervention, aimed at reducing pain severity and duration, 
may play in limiting the longer-term impact of AKP.[14]   
 
Despite the strengths of this systematic review, there are limitations that need to be considered 
when interpreting findings.  Studies were not considered eligible for inclusion if they were 
published in non-English languages.  While it is arguable that authors of high-quality RCTs would 
aim to widely disseminate their findings via high-impact journals published in the English 
language, it is plausible that this may influence outcomes of analyses.  Furthermore, while the use 
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of a rigorous and systematic methodology limits the influence of potential biases, assessment of 
publication bias was not conducted.  Considering that publication bias has been reported for studies 
investigating patellar taping and bracing for chronic knee pain [26], it is possible that publication 
bias also exists among studies of other interventions for AKP, and only highlights the need for 
further high-quality RCTs to ensure that the literature is characterised by more balanced findings.   
 
A number of methodological issues were identified among the included studies that should be 
addressed in future AKP RCTs.  Firstly, the 48 studies initially rated for their methodological 
quality had a mean modified PEDro rating of less than half of the total possible score, and almost 
half of these studies were excluded from further analysis due to a high risk of bias associated with 
the study design or inadequate reporting.  In order to enhance the quality of published studies on 
AKP, and maximise the potential for consolidation of findings in systematic reviews and meta-
analyses, future RCTs should utilise Consolidated Standards of Reporting Trials (CONSORT) 
guidelines [72] during the methodological design phase and when reporting study findings.  This 
would also address the inconsistencies and inadequacies with reporting outcome data that were 
observed, and the subsequent effect that this has on calculation of effect sizes and meta-analyses.  
Secondly, participant numbers were generally low, with final group sizes below 30 for the majority 
of studies.  Only 37 percent of the 48 studies reported sample size calculations, which suggests that 
they may not have been adequately powered to show significant between-group differences.  
Thirdly, only six studies included in final analyses investigated treatment effects beyond three 
months.  In the context of a chronic condition such as AKP,[9] studies of longer duration are 
required to determine the longer-term efficacy of interventions.  
 
While the aim of this systematic review was to investigate the effect of interventions on pain, future 
RCTs should consider using a range of outcome measures that also address other signs and 
symptoms of AKP.  The Kujala Patellofemoral Score [73] which encompasses pain, function and 
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other symptoms, has been shown to be reliable, valid and responsive in AKP,[40] and predictive of 
short- and long-term outcome.[14]  Indeed, it was used as an additional outcome measure in 11 of 
the 48 studies initially included.[11, 14, 40, 45, 48, 55, 60, 66, 74-76]  Ratings of global 
improvement [31] provide an overall opinion of treatment effects on the condition as a whole, and 
can be represented by clinically meaningful statistics such as relative risk reduction and numbers 
needed to treat.  More widespread use of such measures would facilitate further between-study 
comparisons and meta-analyses involving dimensions other than pain. 
 
5. Conclusion 
Pooled data from a limited subset of studies supports the use of multimodal physiotherapy 
incorporating proximal as well as local interventions to reduce AKP in the short term, but does not 
support the addition of EMG biofeedback to exercise.  Due to a lack of further opportunities for 
data pooling, individual RCTs provide the best evidence for other interventions such as exercise, 
patella taping, foot orthoses and acupuncture.  Until further high-quality RCTs are conducted 
addressing issues of sample size, long-term follow up and adherence to the CONSORT statement, 
sports medicine practitioners should prescribe local, proximal and distal components of multimodal 
physiotherapy for appropriate AKP patients, but also consider foot orthoses or acupuncture as 
adjunct or alternative interventions. 
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Table I.  Summary of included studies (N = 27). 
 INTERVENTION:  SAMPLE:  EFFECT SIZE FOR PAIN AT FOLLOW-UP (weeks) 
 
Study (modified 
PEDro rating)  
Duration 
(weeks) 
 
Total randomised 
(total analysed) 
per group 
Mean (SD) 
age (years) 
#median 
Mean (SD) knee 
pain duration 
(months) 
#median (IQR) 
 
Comparison SMD (95% CI) Study conclusions (where effect size = ID) 
MULTIMODAL PHYSIOTHERAPY         
Clark 2000 [43] 
(9/14) 
A: Exercise (quadriceps, gluteals) + 
patella taping + education 
D: Education 
12  A: 20 (16,10) 
D: 22 (21,15) 
A: 26 (7.4) 
B: 27.1 (7.2) 
NR  A vs D 12:  0.12 (-0.53 to 0.77) 
52:  0.33 (-0.47 to 1.14) 
 
Collins 2008 [31] 
(12/14) 
A: Foot orthoses 
B: Flat inserts 
C: Physiotherapy (patella taping, 
vasti retraining with EMG 
biofeedback, gluteal strengthening, 
patella mobilisation, stretches) 
D: Foot orthoses + physiotherapy 
52  A: 46 (41, 42, 45) 
B: 44 (40, 38, 41) 
C: 45 (41, 41, 42) 
D: 44 (42, 40, 43) 
A: 27.9 (5.3) 
B: 29 (6) 
C: 30.9 (5.8) 
D: 29.6 (5.6) 
A: 42 (12.3-96)# 
B: 24 (12-71)# 
C: 37 (12.3-
84.8)# 
D: 24 (9-60)# 
 C vs B (worst) 
 
 
 
C vs A (worst) 
 
 
 
D vs B (worst) 
 
 
 
D vs A (worst) 
 
 
6:  1.10 (0.64 to 1.57) 
12:  0.69 (0.23 to 1.14) 
52:  0.44 (0.01 to 0.88) 
 
6:  0.51 (0.07 to 0.95) 
12:  0.45 (0.01 to 0.88) 
52:  0.37 (-0.05 to 0.80) 
 
6:  1.45 (0.96 to 1.94) 
12:  0.86 (0.40 to 1.33) 
52:  0.77 (0.33 to 1.21) 
 
6:  0.87 (0.42 to 1.32) 
12:  0.63 (0.16 to 1.07) 
52:  0.70 (0.27 to 1.14) 
 
Crossley 2002 [30] 
(13/14) 
A: Physiotherapy (patella taping, 
vasti retraining with EMG 
biofeedback, gluteal strengthening, 
patella mobilisation, stretches) 
B: Sham physiotherapy 
6  A: 36 (33) 
B: 35 (34) 
A: 29 (8) 
B: 26 (8) 
A: 39 (43) 
B: 31 (32) 
 A vs B (worst) 6:  1.05 (0.54 to 1.56)  
Harrison 1999 [44] 
(8/14) 
A: Physiotherapy (patella taping, 
vasti and hip adductor exercises, 
EMG biofeedback) + education  
B: Home exercise program 
(quadriceps, hip adductors) 
monitored by physical therapist + 
education 
C: Home exercise program + 
education 
4  A: 36 (25,20,23,18) 
B: 34 (26,20,15,13) 
C: 42 (23,22,14,18) 
 
22.2 (8.2) NR  A vs C (worst) 
 
 
 
 
A vs B (worst) 
 
 
 
4:  0.33 (-0.24 to 0.90) 
12:  -0.19 (-0.80 to 0.42) 
26:  0.51 (-0.17 to 1.18) 
52:  0.01 (-0.65 to 0.66) 
 
4:  0.56 (0.00 to 1.12) 
12:  -0.33 (-0.95 to 0.30) 
26:  0.11 (-0.54 to 0.76) 
52:  0.04 (-0.67 to 0.76) 
 
Syme 2009 [42] 
(11/14) 
A: Physiotherapy (patella 
mobilisations) with selective VMO 
retraining (EMG biofeedback, 
patella taping) 
B: Physiotherapy with general 
quadriceps strengthening  
C: No-treatment control 
8  A: 23 (21) 
B: 23 (22) 
C: 23 (20) 
A: 28.8 (8) 
B: 27.3 (7.9) 
C: 28.5 (6.4) 
A: 49 (37.5) 
B: 45.5 (35.3) 
C: 50.5 (41.3) 
 A v B 
 
A v C 
 
B v C 
8:  0.11 (-0.49 to 0.71) 
 
8:  0.63 (0.00 to 1.26) 
 
8:  0.49 (-0.13 to 1.10) 
 
 
 29 
 
 INTERVENTION:  SAMPLE:  EFFECT SIZE FOR PAIN AT FOLLOW-UP (weeks) 
 
 Duration (weeks) 
 
Total randomised 
(total analysed) 
per group 
Mean (SD) 
age (years) 
#median 
Mean (SD) knee 
pain duration 
(months) 
#median (IQR) 
 
Comparison SMD (95% CI) Study conclusions (where effect size = ID) 
EXERCISE         
Clark 2000 [43] 
(9/14) 
B: Exercise (quadriceps, gluteals) + 
education 
D: Education 
12  B: 20 (16,12) 
D: 22 (21,15) 
B: 29.5 (6.2) 
D: 27.1 (7.2) 
NR  B vs D 12:  0.28 (-0.37 to 0.93) 
52:  0.30 (-0.47 to 1.06) 
 
Harrison 1999  [44] 
(8/14) 
A: Home exercise program (quadriceps, 
hip adductors) + education 
B: Home exercise program monitored 
by physical therapist + education 
4  A: 42 (23,22,14,18) 
B: 34 (26,20,15,13) 
 
22.2 (8.2) NR  B vs A 4:  -0.22 (-0.78 to 0.34) 
12:  0.12 (-0.49 to 0.73) 
26:  0.36 (-0.38 to 1.09) 
52:  -0.04 (-0.75 to 0.68) 
 
Herrington 2007 
[45] (8/14) 
A: WB knee extension (leg press)  
B: NWB knee extension (sitting) 
C: No-treatment control 
6  A: 15 (15) 
B: 15 (15) 
C: 15 (15) 
26.9 (5.6) NR  A vs C 
 
B vs C 
6:  3.02 (1.93 to 4.11) 
 
6:  1.83 (0.95 to 2.69) 
 
Nakagawa 2008 
[49] (8/14) 
A: Hip + quadriceps exercises 
B: Quadriceps exercises 
6  A: 7 (7) 
B: 7 (7) 
23.6 (5.9) NR  A vs B (worst) 
 
6:  0.83 (-0.28 to 1.93) 
 
 
Song 2009 [46] 
(11/14) 
A: Leg press with hip adduction 
B: Leg press 
C: No-treatment control 
8  A: 29 (27) 
B: 30 (27) 
C: 30 (25) 
A: 38.6 (10.8) 
B: 40.2 (9.9) 
C: 43.9 (9.8) 
A: 41.8 (36.1) 
B: 38.3 (34.2) 
C: 27.7 (41) 
 A vs C 
 
A vs B 
 
B vs C 
8:  0.83 (0.26 to 1.40) 
 
8:  -0.17 (-0.71 to 0.36) 
 
8:  1.01 (0.43 to 1.59) 
 
Taylor 2003 [50] 
(9/14) 
A: Quadriceps exercises + patella 
mobilisation/manipulation 
B: Patella mobilisation/manipulation 
4  A: 6 (6) 
B: 6 (6) 
30.17 (NR) NR  A vs B 5:  0.72 (-0.47 to 1.90)  
Van Linschoten 
2009 [11] (9/14) 
A: Supervised exercise therapy 
B: No-treatment control 
52  A: 65 (65,65) 
B: 66 (66,66) 
A: 24.7 (8.6) 
B: 23.3 (7.8) 
NR  A vs B (activity) 12:  0.44 (0.09 to 0.78) 
52:  0.49 (0.14 to 0.83) 
 
Wiener-Ogilvie 
2004 [51] (9/14) 
A: Foot orthoses  
C: Exercise (quadriceps, hamstrings, 
hip adductors) + foot orthoses 
8  A: 11 (9) 
C: 10 (9) 
A: 38.7 (17.2) 
C: 61.8 (10.3) 
A: 17.9 (17.8) 
C: 29.8 (38) 
 C vs A 4:  0.13 (-0.80 to 1.05) 
8:  0.42 (-0.52 to 1.35) 
 
Closed vs. open chain exercises:         
Bakhtiary 2008 [47] 
(6/14) 
A: Closed kinetic chain exercises (semi-
squat)  
B: Open kinetic chain exercises (SLR) 
3  A: 16 (NR) 
B: 16 (NR) 
A: 21.8 (0.6) 
B: 22.3 (1.7) 
NR  A vs B 5:  0.00 (-0.69 to 0.69)  
Herrington 2007 
[45] (8/14) 
A: WB knee extension (leg press)  
B: NWB knee extension (sitting) 
6  A: 15 (15) 
B: 15 (15) 
26.9 (5.6) NR  A vs B 6:  1.01 (0.25 to 1.78)  
Witvrouw 2000 [76] 
(6/14) 
A: Closed kinetic chain exercises 
B: Open kinetic chain exercises 
(quadriceps, hip adductors) 
5  A: 30 (30) 
B: 30 (30) 
20.3 (NR) 15.1 (NR)  A vs B 5:  ID~ 
12:  ID~ 
Group A had significantly 
greater improvement in night 
pain (p = 0.024) & pain during 
testing (p = 0.028); no 
significant differences on 11 
other pain VAS (p > 0.05). 
Witvrouw 2003 [77] 
(9/14) 
A: Closed kinetic chain exercises 
B: Open kinetic chain exercises 
(quadriceps, hip adductors) 
5  A: 30 (30) 
B: 30 (30) 
20.3 (NR) 15.1 (NR)  A vs B 5:  ID~ 
12:  ID~ 
No significant difference at 5 
& 12 weeks (p>0.05). 
Witvrouw 2004 [48] 
(6/14) 
A: Closed kinetic chain exercises 
B: Open kinetic chain exercises 
(quadriceps, hip adductors) 
5  A: 30 (30) 
B: 30 (30) 
20.3 (NR) 15.1 (NR)  A vs B 12:  0.15 (-0.36 to 0.65) 
260:  -0.57 (-1.14 to 0) 
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 INTERVENTION:  SAMPLE:  EFFECT SIZE FOR PAIN AT FOLLOW-UP (weeks) 
 
 Duration (weeks) 
 
Total randomised 
(total analysed) 
per group 
Mean (SD) age 
(years) 
#median 
Mean (SD) knee 
pain duration 
(months) 
#median (IQR) 
 
Comparison SMD (95% CI) Study conclusions (where effect size = ID) 
TAPE         
Clark 2000 [43] 
(9/14) 
A: Exercise (quadriceps, gluteals) + 
taping + education 
B: Exercise + education 
C: Taping + education 
D: Education 
12  A: 20 (16,10) 
B: 20 (16,12) 
C: 19 (18,12) 
D: 22 (21,15) 
A: 26 (7.4) 
B: 29.5 (6.2) 
C: 29.3 (6.8) 
D: 27.1 (7.2) 
NR  C vs D 
 
 
A vs B 
 
12:  -0.22 (-0.85 to 0.41) 
52:  -0.36 (-1.13 to 0.40) 
 
12:  -0.20 (-0.89 to 0.50) 
52:  0.03 (-0.81 to 0.87) 
 
Whittingham 2004 
[52] (10/14) 
A: Patella taping + exercise 
B: Placebo taping + exercise 
C: Exercise (quadriceps, hip external 
rotators) 
4  A: 10(10) 
B: 10(10) 
C: 10 (10) 
A: 18.8 (1.3) 
B: 18.6 (1.1) 
C: 18.7 (1.4) 
NR  A vs C 
 
A vs B 
4:  2.47 (1.25 to 3.70) 
 
4:  1.35 (0.36 to 2.35) 
 
FOOT ORTHOSES         
Collins 2008 [31] 
(12/14) 
A: Foot orthoses 
B: Flat inserts 
C: Physiotherapy (patella taping, vasti 
retraining with EMG biofeedback, 
gluteal strengthening, patella 
mobilisation, stretches) 
D: Foot orthoses + physiotherapy 
52  A: 46 (41, 42, 45) 
B: 44 (40, 38, 41) 
C: 45 (41, 41, 42) 
D: 44 (42, 40, 43) 
A: 27.9 (5.3) 
B: 29 (6) 
C: 30.9 (5.8) 
D: 29.6 (5.6) 
A: 42 (12.3-96)# 
B: 24 (12-71)# 
C: 37 (12.3-
84.8)# 
D: 24 (9-60)# 
 A vs B (worst) 
 
 
 
A vs C (worst) 
 
 
 
D vs B (worst) 
 
 
 
D vs C (worst) 
6:  0.59 (0.15 to 1.04) 
12:  0.24 (-0.20 to 0.68) 
52:  0.07 (-0.36 to 0.49) 
 
6:  -0.51 (-0.95 to -0.07) 
12:  -0.45 (-0.88 to -0.01) 
52:  -0.37 (-0.80 to 0.05) 
 
6:  1.45 (0.96 to 1.94) 
12:  0.86 (0.40 to 1.33) 
52:  0.77 (0.33 to 1.21) 
 
6:  0.37 (-0.06 to 0.80) 
12:  0.19 (-0.25 to 0.63) 
52:  0.34 (-0.09 to 0.76) 
 
Wiener-Ogilvie 
2004 [51] (9/14) 
A: Foot orthoses  
B:  Exercise (quadriceps, hamstrings, 
hip adductors) 
C: Foot orthoses + exercise 
8  A: 11 (9) 
B: 10 (9) 
C: 10 (9) 
A: 38.7 (17.2) 
B: 51 (22.5) 
C: 61.8 (10.3) 
A: 17.9 (17.8) 
B: 10.6 (8.2) 
C: 29.8 (38) 
 A vs B 
 
 
C vs B 
 
4:  -0.16 (-1.09 to 0.77) 
8:  0.80 (-0.17 to 1.77) 
 
4:  0.01 (-0.91 to 0.93) 
8:  0.87 (-0.17 to 1.85) 
 
MANUAL THERAPY         
Manual PFJ techniques:         
van den Dolder 
2006 [54] (11/14) 
A: PFJ mobilisation 
B: No-treatment control 
2  A: 21 (21) 
B: 17 (16) 
A: 55 (11) 
B: 52 (18) 
A: 26 (12-91) 
B: 39 (15-137) 
 A vs B (average) 
 
2:  0.57 (-0.10 to 1.23) 
 
 
Manipulation:         
Brantingham 2009 
[55] (8/14) 
A: Knee manipulation + exercises + 
soft tissue treatment 
B: Full kinetic chain manipulation + 
exercises + soft tissue treatment 
6  A: 25 (13) 
B: 22 (18) 
A: 27.9 (3.2) 
B: 30.7 (8.1) 
A: 48.5 
B: 54.8 
 A vs B (worst) 2-6:  -0.06 (-0.77 to 0.66) 
10-14:  -0.33 (-1.05 to 0.39) 
 
Stakes 2006 [56] 
(6/14) 
A: Spinal manipulation + patellar 
mobilisation 
B: Patellar mobilisation 
4  A: 30 (28) 
B: 30 (28) 
A: 29 (NR) 
B: 32 (NR) 
NR  A vs B 4:  0.11 (-0.42 to 0.63)  
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 INTERVENTION:  SAMPLE:  EFFECT SIZE FOR PAIN AT FOLLOW-UP (weeks) 
 
 Duration (weeks) 
 
Total randomised 
(total analysed) 
per group 
Mean (SD) age 
(years) 
#median 
Mean (SD) knee 
pain duration 
(months) 
#median (IQR) 
 
Comparison SMD (95% CI) Study conclusions (where effect size = ID) 
ELECTROTHERAPY         
Rogvi-Hansen 1991 
[61] (7/14) 
A: Low level laser treatment 
B: Placebo (sham laser) 
5  A: 20 (19) 
B: 20 (17) 
A: 35 (NR) 
B: 31 (NR) 
A: 48 (NR) 
B: 72 (NR) 
 A vs B 5:  ID 
8-12:  ID 
No statistical difference 
between groups (p>0.05). 
EMG biofeedback:         
Dursun 2001 [57] 
(6/14) 
A: Exercise (quadriceps, VMO) + 
EMG biofeedback 
B: Exercise 
12  A: 30 (30) 
B: 30 (30) 
A: 36.9 (9.2) 
B: 36.6 (10.6) 
A: 10.8 (7.7) 
B: 9.7 (8.1) 
 A vs B 4:  -0.25 (-0.76 to 0.25) 
12:  -0.25 (-0.75 to 0.26) 
 
Yip 2006 [58] (8/14) A: Exercise (quadriceps, VMO) + EMG 
biofeedback 
B: Exercise 
8  A: 13 (13) 
B: 13 (13) 
32.5 (8.8) NR  A vs B 4:  -0.11 (-0.88 to 0.66) 
8:  -0.17 (-0.94 to 0.61) 
 
Electric muscle stimulation:         
Akarcali 2002 [59] 
(7/14) 
A: High voltage pulsed galvanic 
stimulation + exercise (open 
progressing to closed kinetic chain) 
B: Exercise 
6  A: 22 (20) 
B: 22 (22) 
A: 41.6 (9.58) 
B: 36.3 (9.59) 
15.74 (9.31)  A vs B 6:  0.31 (-0.30 to 0.92)  
Callaghan 2004 [60] 
(10/14) 
A: Simultaneous 5-frequency EMS 
B: Single frequency EMS 
6  A: 39 (37) 
B: 41 (37) 
A: 36.5 (13.6) 
B: 33.2 (9.4) 
A: 30.5 (15.25) 
B: 25.75 (15.5) 
 A vs B 6:  ID~ No significant differences 
between groups in post-
treatment pain (p = 0.249). 
ACUPUNCTURE         
Jensen 1999 [53] 
(8/14) 
A: Acupuncture 
B: No-treatment control 
4  A: 37 (36,30,nr) 
B: 38 (34,31,nr) 
A: 29 (NR) 
B: 33.4 (NR) 
 
A: 76.8 (NR) 
B: 81.6 (NR) 
 A vs B 6:  ID 
20:  0.65 (0.13 to 1.16) 
52:  ID 
Did not test control group at 6 
weeks or measure pain at 52 
weeks. 
Qiu 2009 [80] (5/14) A:  Warming needle + exercise 
(quadriceps, hip adductors) 
B:  NSAID (Meloxicam) + exercise 
4  A: 49 (47) 
B: 49 (45) 
A: 54 (NR) 
B: 55 (NR) 
A: 6 (NR) 
B: 12 (NR) 
 A vs B 1:  ID 
2:  ID 
3:  ID 
4:  ID 
No between-group 
comparisons for pain. 
PHARMACOTHERAPY         
Suter 1998 [62] 
(6/14) 
A: NSAID (Naproxen sodium) 
B: Placebo 
1  A: 22 (19) 
B: 20 (17) 
35.6 (8.4) NR  A vs B 1:  ID~ Group A had significantly 
greater reduction in pain than 
Group B in affected and 
unaffected knees (p < 0.05). 
 
NR: not reported in article; ID: inadequate data provided by authors; ~ no significant difference between groups (p = 0.05); ID~ authors only reported statistical significance (between-group) 
n/a: no outcome measure for pain; SMD in bold denotes significant effect; VMO: vastus medialis obliquus; SLR: straight leg raise; WB: weight bearing; NWB: non-weight bearing; ROM: range of motion; 
PNF: proprioceptive neuromuscular facilitation; ITB: iliotibial band; NSAIDs: nonsteroidal anti-inflammatory drugs; TENS: transcutaneous electric nerve stimulation; EMG: electromyography; EMS: electric 
muscle stimulation; NSAID: nonsteroidal anti-inflammatory drug. 
 
 
